建发致新: 首次公开发行股票并在创业板上市初步询价及推介公告

Core Viewpoint - Shanghai Jianda Zhixin Medical Technology Group Co., Ltd. is set to conduct its initial public offering (IPO) and list on the ChiNext board, with the underwriting led by CITIC Securities Co., Ltd. [1][21] Group 1: IPO Details - The total number of shares to be publicly issued is 63,193,277, accounting for approximately 15.00% of the company's total share capital post-IPO [29][30] - The initial strategic placement will involve 12,638,655 shares, representing about 20.00% of the total issuance [30][31] - The initial offline issuance quantity is set at 40,444,122 shares, while the online issuance quantity is 10,110,500 shares [31] Group 2: Issuance Process - The issuance will combine offline inquiries to qualified investors and online pricing for public investors holding non-restricted A-shares [28] - The pricing will be determined through an initial inquiry process, eliminating cumulative bidding [31] - Investors must submit their pricing basis and proposed share quantities through the Shenzhen Stock Exchange's offline issuance electronic platform [4][24] Group 3: Investor Participation - Qualified offline investors must have an average market value of non-restricted A-shares of at least 10 million yuan over the past 20 trading days [13] - Each offline investor can submit up to three different quotes, with a maximum share purchase limit of 20 million shares per allocation [5][6] - The minimum bid increment for pricing is set at 0.01 yuan, and the minimum proposed subscription quantity is 2.5 million shares [5][26] Group 4: Lock-up Period and Allocation - For the offline issuance, 90% of the allocated shares will have no lock-up period, while 10% will be subject to a six-month lock-up period [32] - The strategic placement shares will also have specific lock-up arrangements detailed in the announcement [12][32] - The final allocation of shares will be disclosed in the preliminary allocation results announcement [31][32]